Eagle Pharmaceuticals’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Eagle is a pharmaceutical company that focuses on developing and commercializing injectable products in the critical care and oncology areas. Read more

Eagle is a pharmaceutical company that focuses on developing and commercializing injectable products in the critical care and oncology areas. Read more

Scott Tarriff's photo - President & CEO of Eagle Pharmaceuticals

President & CEO

Scott Tarriff

CEO Approval Rating

92/100

Founded:

2007

Status:

PublicNASDAQEGRX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sagent Pharmaceuticals is perceived as one of Eagle Pharmaceuticals's biggest rivals. Sagent Pharmaceuticals was founded in 2006, and is headquartered in Schaumburg, Illinois. Sagent Pharmaceuticals is in the Pharmaceuticals industry. Sagent Pharmaceuticals generates $120.5M more revenue vs. Eagle Pharmaceuticals.

Auromedics is a top competitor of Eagle Pharmaceuticals. Auromedics is a Private company that was founded in 2011 in Dayton, New Jersey. Auromedics operates in the Health Care Equipment industry. Compared to Eagle Pharmaceuticals, Auromedics has 38 fewer employees.

Custopharm is Eagle Pharmaceuticals's #3 rival. Custopharm is headquartered in Carlsbad, California, and was founded in 2005. Custopharm competes in the Pharmaceuticals industry. Custopharm generates 6.77% the revenue of Eagle Pharmaceuticals.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is West-Ward Pharmaceuticals a competitor of Eagle Pharmaceuticals?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$177.4M

Eagle Pharmaceuticals's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 1.5B. Over the last three quarters, Eagle Pharmaceuticals's revenue has grown by 6.5%. Specifically, in Q2 2020's revenue was $41.9M; in Q1 2020, it was $46M; in Q4 2019, it was $39.4M.

Acquisitions

No recent acquisitions found related to Eagle Pharmaceuticals

Eagle Pharmaceuticals Funding History

$12.3M$62.6M$65.3M

Since Eagle Pharmaceuticals was founded in 2007, it has participated in 3 rounds of funding. In total Eagle Pharmaceuticals has raised $65.3M. Eagle Pharmaceuticals' last funding round was on Nov 2016 for a total of $2.7M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Nov 2016
$2.7M
-
IPO
Feb 2014
$50.3M

Equity
Feb 2011
$12.3M
-

Total Funding: $65.3M

Since Eagle Pharmaceuticals was founded in 2007, it has participated in 3 rounds of funding. In total Eagle Pharmaceuticals has raised $65.3M. Eagle Pharmaceuticals' last funding round was on Nov 2016 for a total of $2.7M

Investments

No recent investments found related to Eagle Pharmaceuticals

Eagle Pharmaceuticals News

September 23, 2020MarketScreener

rsquo; Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021

(marketscreener.com) - Eagle to receive $5 million milestone payment - - RTD and Rapid Infusion formu... See more »
September 8, 2020MarketScreener

to Present at Upcoming September 2020 Healthcare Conferences

(marketscreener.com) Eagle Pharmaceuticals, Inc. today announced that Scott Tarriff, Chief Executive ... See more »
August 19, 2020MarketScreener

Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer's Disease

(marketscreener.com) Eagle Pharmaceuticals, Inc. today announced that preclinical research on dantrol... See more »
June 10, 2020themarketsdaily

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Expected to Post Earnings of $0.37 Per Share

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) will report earnings of $0.37 per share for the current quart... See more »
June 8, 2020MarketScreener

Additional Proxy Soliciting Materials (definitive)

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE... See more »

Eagle Pharmaceuticals Press Releases

November 14, 2019StreetInsider

Eagle Pharmaceuticals Announces Departure of Douglas L. Braunstein from Board of Directors

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Comp... See more »
April 22, 2019Business Wire

CMS Establishes Unique J-Code for BELRAPZO (Bendamustine 500mL Hydrochloride Injection)

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (Nasdaq... See more »
November 27, 2018Business Wire

Eagle Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) ("Eagle" or the "Com... See more »
March 6, 2018MarketersMedia

Blog Exposure - Mylan Plans to Launch Two New HIV Treatments in the US

Stock Monitor: Eagle Pharma Post Earnings ReportingLONDON, UK / ACCESSWIRE / March 06, 2018 / Active-... See more »
March 1, 2017Blackbird

EGRX, SWC, WFC

February 13, 2017Business Wire

Eagle Pharmaceuticals to Present at 2017 RBC Capital Markets Global Healthcare Conference

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that... See more »
January 4, 2017Blackbird

Eagle Pharmaceuticals to Present at J.P. Morgan 35th Annual Healthcare Conference

WOODCLIFF LAKE, N.J.-(BUSINESS WIRE)-Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that S... See more »

Social Statistics

Headquarters

50 Tice Blvd Suite 315

Woodcliff Lake, New Jersey07677

201-326-5300

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Eagle is a pharmaceutical company that focuses on developing and commercializing injectable products in the critical care and oncology areas. Eagle Pharmaceuticals was founded in 2007. Eagle Pharmaceuticals' headquarters is located in Woodcliff Lake, ...

CEO

Eagle Pharmaceuticals's President & CEO, Scott Tarriff, currently has an approval rating of 92%. Eagle Pharmaceuticals's primary competitors are Sagent Pharmaceuticals, Auromedics & Custopharm.

Website

eagleus.com

Frequently Asked Questions about Eagle Pharmaceuticals

  1. When was Eagle Pharmaceuticals founded?

    Eagle Pharmaceuticals was founded in 2007
  2. Who is Eagle Pharmaceuticals's CEO?

    Eagle Pharmaceuticals's CEO is Scott Tarriff
  3. How much revenue does Eagle Pharmaceuticals generate?

    Eagle Pharmaceuticals generates $177.4M in revenue
  4. How much funding does Eagle Pharmaceuticals have?

    Eagle Pharmaceuticals has historically raised $65.3M in funding
  1. Where is Eagle Pharmaceuticals's headquarters?

    Eagle Pharmaceuticals's headquarters is in Woodcliff Lake New Jersey, USA
  2. How many employees does Eagle Pharmaceuticals have?

    Eagle Pharmaceuticals has 96 employees
  3. Who are Eagle Pharmaceuticals's competitors?

    Eagle Pharmaceuticals's top competitors are Sagent Pharmaceuticals, Auromedics, Custopharm